Header Logo

Connection

Robert Balk to Male

Back to Details
This is a "connection" page, showing publications Robert Balk has written about Male.
Robert Balk
Connection Strength
0.718
Male
  1. Respiratory Musculature Evaluated by Computed Tomography in the Setting of Prolonged Mechanical Ventilation. Respir Care. 2023 08; 68(8):1106-1111.
    View in: PubMed
    Score: 0.070
  2. The Role of Biomarkers in the Diagnosis and Management of Pneumonia. Clin Chest Med. 2018 12; 39(4):691-701.
    View in: PubMed
    Score: 0.051
  3. Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study. PLoS One. 2018; 13(10):e0205924.
    View in: PubMed
    Score: 0.051
  4. Role of Integrated Pulmonary Index in Identifying Extubation Failure. Respir Care. 2017 Dec; 62(12):1550-1556.
    View in: PubMed
    Score: 0.047
  5. Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States. Chest. 2017 Jan; 151(1):23-33.
    View in: PubMed
    Score: 0.044
  6. Impact of End-Stage Renal Disease and Acute Kidney Injury on ICU Outcomes in Patients With Sepsis. J Intensive Care Med. 2017 Aug; 32(7):444-450.
    View in: PubMed
    Score: 0.043
  7. Evaluation of Pain, Dyspnea, and Goals of Care Among Adults With Cystic Fibrosis: A Comprehensive Palliative Care Survey. Am J Hosp Palliat Care. 2017 May; 34(4):347-352.
    View in: PubMed
    Score: 0.042
  8. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010 Apr; 33(4):375-80.
    View in: PubMed
    Score: 0.028
  9. A case of flavor-induced lung disease. South Med J. 2008 May; 101(5):541-2.
    View in: PubMed
    Score: 0.025
  10. Diffuse pulmonary nodules in a 25-year-old man with diarrhea and weight loss. Chest. 2008 May; 133(5):1252-5.
    View in: PubMed
    Score: 0.025
  11. Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome. J Crit Care. 2005 Mar; 20(1):111-3.
    View in: PubMed
    Score: 0.020
  12. Evaluation of a Closed Suction System With Integrated Tube-Scraping Technology. Respir Care. 2023 08; 68(8):1023-1030.
    View in: PubMed
    Score: 0.017
  13. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front Immunol. 2021; 12:686240.
    View in: PubMed
    Score: 0.015
  14. Novel application of respiratory muscle index obtained from chest computed tomography to predict postoperative respiratory failure after major non-cardiothoracic surgery. Am J Surg. 2021 Nov; 222(5):1029-1033.
    View in: PubMed
    Score: 0.015
  15. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio. 2021 04 20; 12(2).
    View in: PubMed
    Score: 0.015
  16. Score for Predicting Ventilator Weaning Duration in Patients With Tracheostomies. Am J Crit Care. 2018 11; 27(6):477-485.
    View in: PubMed
    Score: 0.013
  17. Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU. Am J Respir Crit Care Med. 2018 10 01; 198(7):903-913.
    View in: PubMed
    Score: 0.013
  18. In-Hospital Deaths Among Adults With Community-Acquired Pneumonia. Chest. 2018 09; 154(3):628-635.
    View in: PubMed
    Score: 0.012
  19. Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays. Clin Infect Dis. 2018 05 02; 66(10):1504-1510.
    View in: PubMed
    Score: 0.012
  20. Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2017 Jul 15; 65(2):183-190.
    View in: PubMed
    Score: 0.012
  21. Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia. J Infect Dis. 2017 06 15; 215(12):1873-1882.
    View in: PubMed
    Score: 0.012
  22. Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia. Clin Infect Dis. 2016 06 15; 62(12):1471-1478.
    View in: PubMed
    Score: 0.011
  23. Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes. Clin Infect Dis. 2016 08 01; 63(3):300-9.
    View in: PubMed
    Score: 0.011
  24. Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia. Chest. 2016 Oct; 150(4):819-828.
    View in: PubMed
    Score: 0.011
  25. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015 Jul 30; 373(5):415-27.
    View in: PubMed
    Score: 0.010
  26. Pneumothorax effects on pulmonary acoustic transmission. J Appl Physiol (1985). 2015 Aug 01; 119(3):250-7.
    View in: PubMed
    Score: 0.010
  27. Sound transmission in the chest under surface excitation: an experimental and computational study with diagnostic applications. Med Biol Eng Comput. 2014 Aug; 52(8):695-706.
    View in: PubMed
    Score: 0.009
  28. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care. 2011; 15(2):R88.
    View in: PubMed
    Score: 0.008
  29. Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study. Clin Ther. 2010 Jul; 32(7):1285-93.
    View in: PubMed
    Score: 0.007
  30. Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock. Crit Care Med. 2008 Jul; 36(7):1999-2007.
    View in: PubMed
    Score: 0.006
  31. Bacteremia during bronchoalveolar lavage. South Med J. 1986 Dec; 79(12):1496-8.
    View in: PubMed
    Score: 0.006
  32. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. Crit Care Med. 2003 Jun; 31(6):1612-9.
    View in: PubMed
    Score: 0.004
  33. Staging of bronchogenic carcinoma. Chest. 1982 Oct; 82(4):473-80.
    View in: PubMed
    Score: 0.004
  34. Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis. Am J Respir Crit Care Med. 2002 Jul 01; 166(1):16-20.
    View in: PubMed
    Score: 0.004
  35. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA. 2000 Apr 05; 283(13):1723-30.
    View in: PubMed
    Score: 0.004
  36. The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Engl J Med. 1998 Feb 05; 338(6):341-6.
    View in: PubMed
    Score: 0.003
  37. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997 Jul; 25(7):1115-24.
    View in: PubMed
    Score: 0.003
  38. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996 Jun 27; 334(26):1697-702.
    View in: PubMed
    Score: 0.003
  39. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol. 1995 Jun; 22(6):1043-7.
    View in: PubMed
    Score: 0.003
  40. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med. 1995 Jun; 23(6):994-1006.
    View in: PubMed
    Score: 0.003
  41. Medical effectiveness of esophageal balloon pressure manometry in weaning patients from mechanical ventilation. Crit Care Med. 1995 Mar; 23(3):504-9.
    View in: PubMed
    Score: 0.002
  42. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 1995 Mar 22-29; 273(12):934-41.
    View in: PubMed
    Score: 0.002
  43. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA. 1994 Nov 09; 272(18):1433-8.
    View in: PubMed
    Score: 0.002
  44. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994 Jun 15; 271(23):1836-43.
    View in: PubMed
    Score: 0.002
  45. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993 Oct 15; 119(8):771-8.
    View in: PubMed
    Score: 0.002
  46. Adult respiratory distress syndrome. Sequence and importance of development of multiple organ failure. The Prostaglandin E1 Study Group. Chest. 1992 Feb; 101(2):320-6.
    View in: PubMed
    Score: 0.002
  47. Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med. 1991 Aug; 19(8):1060-6.
    View in: PubMed
    Score: 0.002
  48. Hepatic dysfunction in the adult respiratory distress syndrome. Chest. 1989 Apr; 95(4):871-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.